Final treatment outcomes of delamanid-containing regimens in patients with MDR-/XDR-TB in South Korea

Eur Respir J. 2019 Nov 7;54(5):1900811. doi: 10.1183/13993003.00811-2019. Print 2019 Nov.

¹ Dept of Internal Medicine, Pusan National University Hospital, Pusan National University College of Medicine, Busan, South Korea.
² Dept of Chest Medicine, Masan National Tuberculosis Hospital, Masan, South Korea.
³ Division of Pulmonary and Critical Care Medicine, Dept of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
⁴ Division of Pulmonary and Critical Care Medicine, Dept of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
⁵ Dept of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea.
⁶ Dept of Internal Medicine, Dong-A University Hospital, Busan, South Korea.
⁷ Dept of Internal Medicine, Pusan National University Yangsan Hospital, Pusan National University College of Medicine, Yangsan, South Korea sooli10@hanmail.net.

No abstract available

Publication types